Clinical Trial

Diagnostic Evaluation of Viral Persistence in Cervical Cancer

Study acronym: PETCVOCC
Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated January 8, 2026 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study aims to evaluate the diagnostic value of an electroacupuncture-based method for detecting viral persistence (human papillomavirus and SARS-CoV-2) in patients with cervical cancer. The study investigates whether persistent viral signatures can be identified through measurable electrodiagnostic responses at acupuncture points associated with organ systems affected by chronic viral infection. The goal is to assess the feasibility, reproducibility, and potential clinical relevance of this diagnostic approach in oncology patients.
Trial Details
NCT Number NCT07325682
Lead Sponsor Oncology Center,Ministry Of Heath,Uzbekistan
Conditions Cervical Cancer
Enrollment 30 participants
Start Date 2025-04-30
Primary Completion 2026-06-30 (estimated)
Study Completion 2030-12-30 (estimated)
Updated on ClinicalTrials.gov 2026-01-08